Product Images Venlafaxine Hydrochloride

This is a label of a medication product named Venlafaxine Hydrochloride 75mg, which comes in capsules. The label includes information about the manufacturer, lot number, and the expiration date of the medication. Additionally, there are warnings to keep the medication out of reach of children and store at controlled temperatures. However, there is not enough information available about the medical use and side effects of the medication.*

This is a drug interaction table that shows the interactions of several drugs with each other. The drugs mentioned are ethanol, Diazepam, Cimetidine, Ketoconazole, Indinavir, Metoprolol, Imipramine, Lithium, and venlafaxine. The table provides information on the PK Fold Change and 90% Cl Recommendation for Cmax and AUC for these drugs. It also provides recommendations such as avoiding concomitant use, no dose adjustment, and use with caution in patients with hypertension, elderly or hepatic dysfunction.*

This appears to be a drug interaction table containing various drugs and their interaction with other drugs. It includes information such as the recommended dose adjustment, clinical significance, and the change relative to reference value. However, without knowing the context in which this table was obtained or the purpose it serves, it is difficult to provide a more detailed description.*

This is a summary of recommendations for dosing adjustments for the medication Venlafaxine in different special populations. The populations analyzed include individuals with hepatic impairment (cirrhosis, mild, moderate or mild/moderate), renal impairment (hemodialysis), CYP2D6 polymorphism, age (>60) and gender. The recommendations for each population are provided based on the analyte PK fold change and 90% CI. Dosage adjustments ranging from 25% to 50% or greater are recommended depending on the population and the analyte involved.*